Autologous GVHD?
Overview
Authors
Affiliations
mTEC damage risks immune recovery.
Takahama Y J Exp Med. 2021; 219(2).
PMID: 34919145 PMC: 8689664. DOI: 10.1084/jem.20212326.
Veceric-Haler Z, Kojc N, Sever M, Zver S, Svajger U, Pozenel P Front Med (Lausanne). 2021; 8:708744.
PMID: 34368198 PMC: 8334176. DOI: 10.3389/fmed.2021.708744.
Lehman J, Hashmi S, Lazarus H, El-Azhary R, Gibson L, Hogan W J Cutan Pathol. 2017; 44(12):1087-1091.
PMID: 28906023 PMC: 5942197. DOI: 10.1111/cup.13019.
Late recurrence of autologous GvHD in a myeloma patient: a myth or diagnostic challenge?.
El-Jurdi N, Ueda M, Jia L, Lazarus H Bone Marrow Transplant. 2017; 52(6):910-912.
PMID: 28319078 DOI: 10.1038/bmt.2017.20.
The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease.
Staffas A, Burgos da Silva M, van den Brink M Blood. 2016; 129(8):927-933.
PMID: 27940475 PMC: 5324712. DOI: 10.1182/blood-2016-09-691394.